NewsColony

NewsColony Early Heparin therapy improves hypoxia in COVID-19 patients The systemic use of heparin for treating severe coronavirus disease (COVID-19) showed significant improvements in oxygen exchange and overall clinical presentation of patients, as reported by a study from Brazil available on a preprint server medRxiv . The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is placing a tremendous burden on critical care. Intensive care units have, thus far, based their protocols on previous experiences with influenza and other viral infections. Study: Heparin therapy improving hypoxia in COVID-19 patients – a case series. Image Credit: DaViDa S / Shutterstock Coagulation disturbances as a hallmark of COVID-19 disease Since the inception of the COVID-19 pandemic, the severity of the disease has been associated with markers of coagulation disturbances and independently linked to the development of respiratory failure, hypoxia (low oxygen...